Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass balance and metabolite profiling study of intravenous radiolabeled APD421 in healthy men
NL-OMON42878Active, not recruiting
- Sponsor
- Acacia Pharma Group Plc
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of amisulpride in Nausea and Vomiting, sponsored by Acacia Pharma Group Plc. Primary endpoints: Mass balance recovery, Metabolite identification and 1 more. Started Jul 2016; status: active, not recruiting.
02
Drugs
amisulpride
03
Conditions
Nausea and Vomiting
Beyond the preview
Go deeper on NL-OMON42878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42878.